Related Experiment Video
Updated: Oct 8, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells
Josep M Monné Rodríguez1,2,3, Sonja Fonfara1,4, Udo Hetzel1,2
1The Veterinary Cardiac Pathophysiology Consortium.
Insights
Microvascular changes and interstitial cell alterations are key in feline hypertrophic cardiomyopathy (fHCM) development. Resident macrophages and CD34+ progenitor cells contribute to the disease
Area of Science:
- Cardiology
- Veterinary Pathology
- Cell Biology
Background:
- Feline hypertrophic cardiomyopathy (fHCM) pathogenesis remains unclear.
- fHCM involves interstitial remodeling, inflammation, and potential myocardial ischemia.
- Understanding structural changes in fHCM is crucial for diagnosis and treatment.
Purpose of the Study:
- Investigate structural changes in interstitial remodeling in fHCM.
- Focus on myocardial microvasculature and interstitial cell phenotypes.
- Elucidate the role of specific cell populations in fHCM.
Main Methods:
- Immunohistochemistry
- RNA-in situ hybridization
- Transmission electron microscopy
- Morphometrical evaluations
Main Results:
- Reduced microvascular density in fHCM hearts.
- Capillary structural alterations and interstitial widening.
- Accumulation of edema, collagen, and mononuclear cells.
- Interstitial cells include fibroblasts, vascular cells, and resident macrophages.
- CD34 mRNA expression suggests progenitor cell potential.
Conclusions:
- Microvascular alterations are central to fHCM pathogenesis.
- Interstitial cell populations, particularly CD34+ cells, are implicated in fHCM.
- Macrophages play a significant role in the pro-inflammatory environment of fHCM.
Abstract:
The sequence of pathological events in feline hypertrophic cardiomyopathy (fHCM) is still largely unknown, although we know that fHCM is characterized by interstitial remodeling in a macrophage-driven pro-inflammatory environment and that myocardial ischemia might contribute to its progression. This study aimed to gain further insights into the structural changes associated with interstitial remodeling in fHCM with special focus on the myocardial microvasculature and the phenotype of the interstitial cells. Twenty-eight hearts (16 hearts with fHCM and 12 without cardiac disease) were evaluated in the current study, with immunohistochemistry, RNA-in situ hybridization, and transmission electron microscopy. Morphometrical evaluations revealed a statistically significant lower microvascular density in fHCM. This was associated with structural alterations in capillaries that go along with a widening of the interstitium due to the accumulation of edema fluid, collagen fibers, and mononuclear cells that also proliferated locally. The interstitial cells were mainly of fibroblastic or vascular phenotype, with a substantial contribution of predominantly resident macrophages. A large proportion expressed CD34 mRNA, which suggests a progenitor cell potential. Our results indicate that microvascular alterations are key events in the pathogenesis of fHCM and that myocardial interstitial cell populations with CD34+ phenotype play a role in the pathogenesis of the disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology

